The following quote is an example of truly stunning ignorance of costs in the biopharma sphere.
Next time you go to the AGM instead of sniffing around try asking Itescu why the share price has gone backwards for 10 years or what they have to show for the $500m they have raised in that same time.
DYOR on costs to get one treatment from an idea to the end of a Phase 3 trial. While your at it try that for Big Pharma and a cellular medicine candidate.
MSB Trading - 2020, page-2766
-
- There are more pages in this discussion • 20,395 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |